Publications by authors named "J Sutphin"

Article Synopsis
  • A study examined patient preferences for different types of pacemakers, including new dual-chamber leadless options and traditional transvenous ones, to identify which features are most important to them.
  • Surveying 117 patients, researchers found that half preferred leadless pacemakers while the other half favored conventional ones, highlighting a significant division in choices.
  • Key factors influencing patient decisions included preferred pacemaker type, acceptance of complication and infection risks, and the time since regulatory approval, with many willing to accept higher risks for their preferred options.
View Article and Find Full Text PDF
Article Synopsis
  • In 2019, the FDA warned that devices coated with paclitaxel for treating claudication might be linked to higher mortality rates over five years, prompting a study to explore patient preferences between risks of revascularization and mortality.
  • A survey involving 272 patients from seven medical centers used discrete-choice experiments to assess how much increased mortality risk they would accept in exchange for decreased chances of needing further procedures on their blood vessels.
  • Results indicated that patients would generally tolerate a small increase in 5-year mortality risk (up to 12.6%) to achieve significant reductions in treatment risks, though there was notable variability in individual risk tolerance, highlighting the need for tailored decision-making support.
View Article and Find Full Text PDF

Introduction: Despite decades of research on risk-communication approaches, questions remain about the optimal methods for conveying risks for different outcomes across multiple time points, which can be necessary in applications such as discrete choice experiments (DCEs). We sought to compare the effects of 3 design factors: 1) separated versus integrated presentations of the risks for different outcomes, 2) use or omission of icon arrays, and 3) vertical versus horizontal orientation of the time dimension.

Methods: We conducted a randomized study among a demographically diverse sample of 2,242 US adults recruited from an online panel (mean age 59.

View Article and Find Full Text PDF

To describe development of a shared decision making (SDM) aid in treating primary immunodeficiency diseases (PID) with immunoglobulin replacement therapy (IGRT). Expert engagement and qualitative formative research informed development. IGRT administration features were prioritized using object-case best-worst scaling (BWS) methodology.

View Article and Find Full Text PDF

Objective: We aimed to assess the feasibility of developing a discrete-choice experiment survey to elicit preferences for a treatment to delay cognitive decline among people with a clinical syndrome consistent with early Alzheimer's disease, including the development of self-reported screening criteria to recruit the sample.

Methods: Using input from qualitative interviews, we developed a discrete-choice experiment survey containing a multifaceted beneficial treatment attribute related to slowing cognitive decline for respondents with self-reported cognitive concerns. In two rounds of in-person pretest interviews, we tested and revised the survey text and discrete-choice experiment questions, including examples, language, and levels associated with the Alzheimer's Disease Assessment Scale-Cognitive Subscale, along with a set of de novo self-reported questions for identifying respondents who had neither too mild nor too advanced cognitive decline.

View Article and Find Full Text PDF